The promise of SGLT2 inhibitors
Interesting drug with potentially huge implications for health care spending. Not only is kidney dialysis incredibly annoying for patients, it’s about 1% of total federal spending.
Interesting drug with potentially huge implications for health care spending. Not only is kidney dialysis incredibly annoying for patients, it’s about 1% of total federal spending.